The Food and Drug Administration official who allegedly had an inappropriately cozy relationship with the maker of the controversial Alzheimer's drug Aduhelm is stepping down from his role, effective immediately, according to numerous media reports.Billy Dunn, head of the FDA's neuroscience office, has been with the agency for around 18 years, during which he was involved in several high-profile drug approvals.
[
add
]
[
|
|
...
]